Transcriptional regulation of vaccine-elicited and infection-elicited CD8+ T cell responses
Transcriptional regulation of vaccine-elicited and infection-elicited CD8+ T cell responses
批准号:
10083688
负责人:
Ross M Kedl
金额:
$38.88万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-01-01 至 2022-12-31
关键词:
AdjuvantAerobicAgonistAgreementAnti-Inflammatory AgentsAntigensAttenuated VaccinesB-LymphocytesBiologyBiomassCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCell physiologyCellsCellular ImmunityClinicalDataDevelopmentElementsEnergy-Generating ResourcesEquilibriumExplosionFDA approvedFamilyFormulationFutureGenerationsGenetic TranscriptionGlycolysisHerpesvirus 1HumanIRF4 geneImmuneImmune responseImmune systemImmunityImmunizationInfectionInfectious AgentInterleukin-12Interleukin-15InvestigationLightListeria monocytogenesLiteratureLymphocytic choriomeningitis virusMediatingMemoryMetabolicMetabolismMethodsMitochondriaModelingMolecularMusNaturePathologyPathway interactionsPrimatesProcessPropertyProto-Oncogene Proteins c-aktPublishingRespirationRoleSignal TransductionSubunit VaccinesT cell responseT memory cellT-Cell ActivationT-LymphocyteTNFRSF5 geneTestingThinkingToll-like receptorsTranscriptional RegulationVaccinationVaccine AdjuvantVaccine ProductionVaccinesVaccinia virusViral VectorYellow Fever Vaccineaerobic glycolysisanti-cancerantigen challengebaseclinically relevantcytokineglycosylationinflammatory milieumouse modelnonhuman primatenovelprogramsresponsetranscription factorvaccination strategyvaccine developmentvaccine discovery
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Immunization with antigen in the presence of agonists for both a Toll Like Receptor (TLR) and CD40
(combined TLR/CD40 immunization) elicits a vigorous expansion of antigen-specific CD8+ T cells that is
exponentially greater than the response elicited by either agonist alone. Not only is the primary immune
response to this vaccination robust, it also forms long lived, CD8+ T cell memory that can protect against future
infectious challenge even in the absence of CD4+ T cells. This has been recently verified in non-human
primates, where the vaccine produced responses exponentially stronger than responses to typical viral vectors.
Given the potency and clinical potential for this vaccine adjuvant platform, it is critical that we understand its
molecular and cellular mechanistic underpinnings. We made the discovery that T cell responses to adjuvanted
subunit vaccinations were unexpectedly and completely dependent on the cytokines IL-27 and IL-15. This was
surprising because the T cell response to an infectious challenge proceeds unabated, and can even be
elevated (for IL-27 deficiency), in the absence of these cytokines. More recently, we have identified the
expression of the transcription factor IRF4 as a major result of IL-27/15 signaling during vaccination. IRF4 is
well documented to facilitate aerobic glycosylation as the source of energy and biomass generation for T cells
during the primary immune response. However, we found that T cells responding to vaccination almost
exclusively utilized mitochondrial respiration, a metabolism that is supposed to be used only by naïve and
memory T cells and not cells undergoing the dramatic proliferative burst of the primary response. Thus, IRF4
appears to be facilitating very different kinds of metabolic programs in a T cell depending on whether or not it
has been encountered the inflammatory environment of a subunit vaccine or of an infection. These and other
observations make us conclude that the rules behind robust subunit vaccine-elicited immunity appear to be
substantially different than those guiding infectious responses. This proposal will use cutting edge methods
and approaches to fully understand the nature of this difference and will test i) how IL-27 and IL-15 influence
downstream transcription factor networks, ii) how these transcriptional elements are tied into vaccine- vs.
infection-driven programs of T cell activation and expansion, and iii) how the earliest T-DC interactions might
influence both transcription factor expression and downstream influence on metabolic programming of the
primary CD8+ T cell response.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
mRNA encoding of immune receptor-targeting antibodies for the augmentation of vaccine-elicited cellular immunity.
-
批准号:10508093
-
项目类别:
-
资助金额:$23.33万
-
财政年份:2022
-
负责人:Ross M Kedl
-
依托单位:
mRNA encoding of immune receptor-targeting antibodies for the augmentation of vaccine-elicited cellular immunity.
-
批准号:10662571
-
项目类别:
-
资助金额:$19.44万
-
财政年份:2022
-
负责人:Ross M Kedl
-
依托单位:
Exploring the heterogeneity of the vaccine-elicited T cell response by scRNAseq
-
批准号:10334559
-
项目类别:
-
资助金额:$19.44万
-
财政年份:2021
-
负责人:Ross M Kedl
-
依托单位:
Exploring the heterogeneity of the vaccine-elicited T cell response by scRNAseq
-
批准号:10218805
-
项目类别:
-
资助金额:$23.33万
-
财政年份:2021
-
负责人:Ross M Kedl
-
依托单位:
CD8 T cell and B cell collaboration following subunit vaccination
-
批准号:10450847
-
项目类别:
-
资助金额:$48.57万
-
财政年份:2020
-
负责人:Ross M Kedl
-
依托单位:
CD8 T cell and B cell collaboration following subunit vaccination
-
批准号:10662244
-
项目类别:
-
资助金额:$47.76万
-
财政年份:2020
-
负责人:Ross M Kedl
-
依托单位:
CD8 T cell and B cell collaboration following subunit vaccination
-
批准号:10055979
-
项目类别:
-
资助金额:$52.42万
-
财政年份:2020
-
负责人:Ross M Kedl
-
依托单位:
CD8 T cell and B cell collaboration following subunit vaccination
-
批准号:10242218
-
项目类别:
-
资助金额:$49.37万
-
财政年份:2020
-
负责人:Ross M Kedl
-
依托单位:
Molecular and cellular basis of Combined Adjuvant-Elicited Cellular Immunity
-
批准号:9312770
-
项目类别:
-
资助金额:$50.05万
-
财政年份:2016
-
负责人:Ross M Kedl
-
依托单位:
Molecular and cellular basis of Combined Adjuvant-Elicited Cellular Immunity
-
批准号:9197094
-
项目类别:
-
资助金额:$52.02万
-
财政年份:2016
-
负责人:Ross M Kedl
-
依托单位:
Lymphatic endothelial cell capture and maintenance of antigen
-
批准号:8895716
-
项目类别:
-
资助金额:$38.2万
-
财政年份:2015
-
负责人:Ross M Kedl
-
依托单位:
Virtual Memory T Cell Development and Responses In Vivo
-
批准号:9023407
-
项目类别:
-
资助金额:$35.02万
-
财政年份:2013
-
负责人:Ross M Kedl
-
依托单位:
Virtual Memory T Cell Development and Responses In Vivo
-
批准号:9222698
-
项目类别:
-
资助金额:$35.02万
-
财政年份:2013
-
负责人:Ross M Kedl
-
依托单位:
Virtual Memory T Cell Development and Responses In Vivo
-
批准号:8436534
-
项目类别:
-
资助金额:$35.6万
-
财政年份:2013
-
负责人:Ross M Kedl
-
依托单位:
Virtual Memory T Cell Development and Responses In Vivo
-
批准号:8634018
-
项目类别:
-
资助金额:$35.31万
-
财政年份:2013
-
负责人:Ross M Kedl
-
依托单位:
Antigen Persistence and Protective Immunity After Protein Vaccination
-
批准号:8502418
-
项目类别:
-
资助金额:$18.62万
-
财政年份:2012
-
负责人:Ross M Kedl
-
依托单位:
Antigen Persistence and Protective Immunity After Protein Vaccination
-
批准号:8386477
-
项目类别:
-
资助金额:$24.08万
-
财政年份:2012
-
负责人:Ross M Kedl
-
依托单位:
Combined TLR/CD40-Agonist Induced CD8+ T Cell Memory
-
批准号:8305322
-
项目类别:
-
资助金额:$38.68万
-
财政年份:2011
-
负责人:Ross M Kedl
-
依托单位:
IFNalphaBeta-Dependent and-Independent TLR/CD40 Synergy
-
批准号:7745527
-
项目类别:
-
资助金额:$37.39万
-
财政年份:2007
-
负责人:Ross M Kedl
-
依托单位:
IL-27 in Vaccine-Elicited Cellular Immunity
-
批准号:8586517
-
项目类别:
-
资助金额:$38.1万
-
财政年份:2007
-
负责人:Ross M Kedl
-
依托单位:
海外基金